Time-varying Markov Models (Non-Homogeneous)

Model description

This example is an implementation of the assessment of a new total hip replacement (THR) technology described in chapter 3.5 of Decision Modelling for Health Economic Evaluation. A more detailed report is available at this location. This reports goes a bit further in the analysis. For the sake of simplicity we will not reproduce exactly the analysis from the book. See vignette vignette("i-reproduction", "heemod") for an exact reproduction.

This model has 5 states:

Primary THR: starting state, individuals receive either the standard or the new THR (called NP1), outcomes are either success of primary THR or death (the operative mortality rate of primary THR will be called omrPTHR);
Success of primary THR: state after receiving primary THR if the surgery is successfull, individuals can stay in that state, need a THR revision, or die of other causes;
Revision of primary THR: for individuals whose primary THR needed revision, outcomes are either success of revision THR or death (the operative mortality rate of revision THR will be called omrRTHR);
Success of revision THR: state after receiving revision THR if the surgery is successfull, individuals can stay in that state, need a THR re-revision, or die of other causes;
Death (either caused by THR or another cause).

Two transition probabilities are time-varying in this model:

Probability of death by another cause increases with age;
Probability of primary THR revision changes with time.

Other-Cause death

Other-cause death probabilities (mortality rate mr) for the United Kingdom is taken from WHO databases using the get_who_mr() function. The variable sex, taking values 0 and 1, must be recoded in "FMLE" and "MLE" before being passed to this function.

THR revision

Primary THR revision probability for the standard THR, called standardRR increases with time with the following formula (a Weibull distribution):

\[ P_{revision} = 1 - \exp(\lambda \times ((t-1)^\gamma-t^\gamma)) \]

Where \(t\) is the time since revision, \(\gamma = 1.45367786\) and:

\[ \lambda = exp(cons + ageC \times age + maleC \times sex) \]

Where \(age\) and \(sex\) (female = 0, male = 1) are individual characteristics, \(cons = -5.49094\), \(ageC = -0.0367\) and \(maleC = 0.768536\).

For the NP1 procedure the standard procedure revision probability standardRR is modified by the relative risk \(rrNP1 = 0.260677\).

\[ P_{revision} = 1 - \exp(\lambda \times rr \times NP1 \times ((t-1)^\gamma-t^\gamma)) \]

Revision THR re-revision (rrr) probability is set to be constant at 0.04 per year.

Parameter definition

The key element to specify time-varying elements in heemod is through the use of the package-defined variables markov_cycle and state_cycle. See vignette vignette("b-time-dependency", "heemod") for more details.

In order to build this more complex Markov model, parameters need to be defined through define_parameters() (for 2 reasons: to keep the transition matrix readable, and to avoid repetition by re-using parameters between strategies).

The equations decribed in the previous section can be written easily, here for a female population (sex = 0) starting at 60 years old (age_init = 60).

param <- define_parameters(
    age_init = 60,
    sex = 0,
    
    # age increases with cycles
    age = age_init + markov_cycle,
    
    # operative mortality rates
    omrPTHR = .02,
    omrRTHR = .02,
    
    # re-revision mortality rate
    rrr = .04,
    
    # parameters for calculating primary revision rate
    cons = -5.49094,
    ageC = -.0367,
    maleC = .768536,
    lambda = exp(cons + ageC * age_init + maleC * sex),
    gamma = 1.45367786,
    
    rrNP1 = .260677,
    
    # revision probability of primary procedure
    standardRR = 1 - exp(lambda * ((markov_cycle - 1) ^ gamma -
                                     markov_cycle ^ gamma)),
    np1RR = 1 - exp(lambda * rrNP1 * ((markov_cycle - 1) ^ gamma - 
                                        markov_cycle ^ gamma)),
    
    # age-related mortality rate
    sex_cat = ifelse(sex == 0, "FMLE", "MLE"),
    mr = get_who_mr(age, sex_cat, country = "GBR", local = TRUE),
    
    # state values
    u_SuccessP = .85,
    u_RevisionTHR = .30,
    u_SuccessR = .75,
    c_RevisionTHR = 5294
)
param

## 20 unevaluated parameters.
## 
## age_init = 60
## sex = 0
## age = age_init + markov_cycle
## omrPTHR = 0.02
## omrRTHR = 0.02
## rrr = 0.04
## cons = -5.49094
## ageC = -0.0367
## maleC = 0.768536
## lambda = exp(cons + ageC * age_init + maleC * sex)
## gamma = 1.45367786
## rrNP1 = 0.260677
## standardRR = 1 - exp(lambda * ((markov_cycle - 1)^gamma - markov_cycle^gamma))
## np1RR = 1 - exp(lambda * rrNP1 * ((markov_cycle - 1)^gamma - markov_cycle^gamma))
## sex_cat = ifelse(sex == 0, "FMLE", "MLE")
## mr = get_who_mr(age, sex_cat, country = "GBR", local = TRUE)
## u_SuccessP = 0.85
## u_RevisionTHR = 0.3
## u_SuccessR = 0.75
## c_RevisionTHR = 5294

Transition matrix definition

Now that parameters are defined, the probability transitions can be easily written:

mat_standard <- define_transition(
    state_names = c(
      "PrimaryTHR",
      "SuccessP",
      "RevisionTHR",
      "SuccessR",
      "Death"
    ),
    0, C, 0,          0, omrPTHR,
    0, C, standardRR, 0, mr,
    0, 0, 0,          C, omrRTHR+mr,
    0, 0, rrr,        C, mr,
    0, 0, 0,          0, 1
)
mat_standard

## A transition matrix, 5 states.
## 
##             PrimaryTHR SuccessP RevisionTHR SuccessR Death       
## PrimaryTHR             C                             omrPTHR     
## SuccessP               C        standardRR           mr          
## RevisionTHR                                 C        omrRTHR + mr
## SuccessR                        rrr         C        mr          
## Death                                                1

mat_np1 <- define_transition(
    state_names = c(
      "PrimaryTHR",
      "SuccessP",
      "RevisionTHR",
      "SuccessR",
      "Death"
    ),
    0, C, 0,          0, omrPTHR,
    0, C, np1RR,      0, mr,
    0, 0, 0,          C, omrRTHR+mr,
    0, 0, rrr,        C, mr,
    0, 0, 0,          0, 1
)
mat_np1

## A transition matrix, 5 states.
## 
##             PrimaryTHR SuccessP RevisionTHR SuccessR Death       
## PrimaryTHR             C                             omrPTHR     
## SuccessP               C        np1RR                mr          
## RevisionTHR                                 C        omrRTHR + mr
## SuccessR                        rrr         C        mr          
## Death                                                1

While it is possible to plot the matrix thanks to the diagram package, the results may not always be easy to read.

plot(mat_standard)

## Le chargement a nécessité le package : diagram

State & strategy definition

Utilities and costs are then associated to states. In this model costs are discounted at a rate of 6% and utilities at a rate of 1.5%.

Now that parameters, transition matrix and states are defined we can define the strategies for the control group and the NP1 treatment.

We use define_starting_values() to take into account the cost of surgery.

strat_standard <- define_strategy(
  transition = mat_standard,
  PrimaryTHR = define_state(
    utility = 0,
    cost = 0
  ),
  SuccessP = define_state(
    utility = discount(u_SuccessP, .015),
    cost = 0
  ),
  RevisionTHR = define_state(
    utility = discount(u_RevisionTHR, .015),
    cost = discount(c_RevisionTHR, .06)
  ),
  SuccessR = define_state(
    utility = discount(u_SuccessR, .015),
    cost = 0
  ),
  Death = define_state(
    utility = 0,
    cost = 0
  ),
  starting_values = define_starting_values(
    cost = 394
  )
)
strat_standard

## A Markov model strategy:
## 
##     5 states,
##     2 state values

strat_np1 <- define_strategy(
  transition = mat_np1,
  PrimaryTHR = define_state(
    utility = 0,
    cost = 0
  ),
  SuccessP = define_state(
    utility = discount(u_SuccessP, .015),
    cost = 0
  ),
  RevisionTHR = define_state(
    utility = discount(u_RevisionTHR, .015),
    cost = discount(c_RevisionTHR, .06)
  ),
  SuccessR = define_state(
    utility = discount(u_SuccessR, .015),
    cost = 0
  ),
  Death = define_state(
    utility = 0,
    cost = 0
  ),
  starting_values = define_starting_values(
    cost = 579
  )
)
strat_np1

## A Markov model strategy:
## 
##     5 states,
##     2 state values

Model analysis

Both strategies can now be run for 60 years. By default models are computed for 1000 person starting in PrimaryTHR.

res_mod <- run_model(
  standard = strat_standard,
  np1      = strat_np1,
  parameters = param,
  cycles = 60,
  cost = cost,
  effect = utility
)

## Fetching mortality data from package cached data.

## Using cached data from year 2015.

A comparison of both strategies can be done with summary(). The incremental cost and effect are displayed in columns Cost and Effect.

summary(res_mod)

## 2 strategies run for 60 cycles.
## 
## Initial state counts:
## 
## PrimaryTHR = 1000L
## SuccessP = 0L
## RevisionTHR = 0L
## SuccessR = 0L
## Death = 0L
## 
## Counting method: 'life-table'.
## 
##  
## 
## Counting method: 'beginning'.
## 
##  
## 
## Counting method: 'end'.
## 
## Values:
## 
##           utility     cost
## standard 16239.62 529400.8
## np1      16291.79 614827.1
## 
## Efficiency frontier:
## 
## standard -> np1
## 
## Differences:
## 
##     Cost Diff. Effect Diff.     ICER     Ref.
## np1   85.42637   0.05216416 1637.645 standard

The new treatment costs £1638 more per QALY gained.

It should be noted that this result differs from the original study. This difference is explained by higher population-level all-causes mortality rates in the original study than in the WHO database (used here). See vignette vignette("i-reproduction", "heemod") for an exact reproduction of the analysis.

We can plot the counts per state:

plot(res_mod, type = "counts", panel = "by_state", free_y = TRUE) +
  theme_bw() +
  scale_color_brewer(
    name = "Strategy",
    palette = "Set1"
  )

## Scale for 'colour' is already present. Adding another scale for 'colour',
## which will replace the existing scale.

2020-12-07